WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

WuXi AppTec, has announced the expansion of its facilities in San Diego, California. The facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing. The expansion will provide key elements of WuXi’s small molecule capability and technology platform under one roof, further enhancing services to North American pharmaceutical and biotech industries. WuXi will also add extensively from the local talent base, further contributing to regional economic growth.

WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help worldwide customers and partners, shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.